Abstract Treatment failure (TF) jeopardizes the management of parasitic diseases, including
leishmaniasis. From the parasite's point of view, drug resistance (DR) is generally …

Leishmaniasis is one of the major public health concerns in Latin America, Africa, Asia, and
Europe. The absence of vaccines for human use and the lack of effective vector control …

Background Protists of the family Trypanosomatidae (phylum Euglenozoa) have gained
notoriety as parasites affecting humans, domestic animals, and agricultural plants. However …

Background Surveillance of human leishmaniasis in Europe is mostly limited to country-
specific information from autochthonous infections in the southern part. As at the end of …

Leishmania are protozoan parasites transmitted by the bite of sand fly vectors producing a
wide spectrum of diseases in their mammalian hosts. These diverse clinical outcomes are …

The tropical Andes are an important natural laboratory to understand speciation in many
taxa. Here we examined the evolutionary history of parasites of the Leishmania braziliensis …

Leishmania infantum causes visceral leishmaniasis, a deadly vector-borne disease
introduced to the Americas during the colonial era. This non-native trypanosomatid parasite …

Background Leishmaniasis is a common neglected tropical disease in Ethiopia. Visceral
leishmaniasis (VL) caused by Leishmania donovani presents in the lowlands, while …

Leishmania, a unicellular eukaryotic parasite, is a unique model for aneuploidy and cellular
heterogeneity, along with their potential role in adaptation to environmental stresses. Somy …

The lack of safe and cost-effective treatments against leishmaniasis highlights the urgent
need to develop improved leishmanicidal agents. Antimicrobial peptides (AMPs) are an …